Vinayak Bapat, Eric Weiss, Tanvir Bajwa, Vinod H Thourani, Pradeep Yadav, Jeremy J Thaden, D Scott Lim, Michael Reardon, Sean Pinney, David H Adams, Steven J Yakubov, Thomas Modine, Simon R Redwood, Antony Walton, Konstantinos Spargias, Angie Zhang, Michael Mack, Martin B Leon
BACKGROUND: Thirty-day outcomes with the investigational Intrepid transapical (TA) transcatheter mitral valve replacement (TMVR) system have previously demonstrated good technical success, but longer-term outcomes in larger cohorts need to be evaluated. OBJECTIVES: The authors sought to evaluate the 2-year safety and performance of the Intrepid TA-TMVR system in patients with symptomatic, ≥moderate-severe mitral regurgitation (MR) and high surgical risk...
April 1, 2024: JACC. Cardiovascular Interventions